During the past decade, Gloucestershire primary care conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gloucestershire primary care" are "Human Papillomavirus Virus" (1 trials), "Immunization" (1 trials), "Immunization; Infection" (1 trials), "Influenza" (1 trials) and "Influenza Vaccination" (1 trials). Many other conditions were trialed in "Gloucestershire primary care" in a lesser frequency.

Most popular intervention types in "Gloucestershire primary care" are "Other" (3 trials), "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fluenz Tetra (The two groups are defined by immunisation history, all receive the same intervention in the study)" (1 trials), "Meningococcal vaccine" (1 trials), "Pertussis containing vaccine" (1 trials), "nasal swab" (1 trials) and "nasopharyngeal swab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gloucestershire primary care" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gloucestershire primary care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gloucestershire primary care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gloucestershire primary care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".